MetaCap

Cumberland Pharmaceuticals (CPIX) vs Polaryx Therapeutics (PLYX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Polaryx Therapeutics is the larger company by market cap ($104.2 million vs $103.2 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX+78.50%PLYX-94.03%
+144%+19%-106%
Feb 2, 20261 yearOct 7, 2026
CPIX+76.21%PLYX-76.54%
+126%+19%-87%
Feb 2, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus PLYX key metrics
MetricCPIXPLYX
Share price$6.89$2.09
Market cap$103.23M$104.18M
1-day change-3.50%-0.48%
YTD return+73.12%—
1-year return+93.54%—
5-year return+151.46%—
Forward P/E49.21—
EPS (TTM)$-0.62$-0.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$9.28$48.91
52-week low$1.85$1.85
Distance from 52-week high-25.75%-95.73%
Average volume87.97K76.38K
Shares outstanding14.98M49.85M
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

CPIX vs PLYX FAQ

Which is bigger, Cumberland Pharmaceuticals or Polaryx Therapeutics?

Polaryx Therapeutics (PLYX) is larger, with a market capitalization of $104.18M compared with $103.23M for Cumberland Pharmaceuticals (CPIX).

Are Cumberland Pharmaceuticals and Polaryx Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons